Nutritional composition for treating an immune condition

a technology for immune conditions and nutritional compositions, applied in the direction of drug compositions, immunological disorders, metabolism disorders, etc., can solve the problems of reducing physical activity, reducing caloric requirements among the elderly, and reducing the number of functioning

Inactive Publication Date: 2005-09-22
NESTEC SA
View PDF4 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0051] An advantage of the present invention is that it provides a nutritional composition in the form of a powder or dry granulate that can be dissolved instantaneously in water to provide a beverage or soup. It does not require cooking.
[0052] Another advantage of the present invention is that it provides a single composition that can be adapted and administered simply in a food for the prevention or treatment an immune condition. The composition can be provided in clinical or performance nutrition settings and is particularly suitable for an elderly patient.
[0020] Advantages in treating immune conditions provided by the probiotic bacteria include prevention or inhibition of diarrhea brought about by pathogenic bacteria; prevention or inhibition of diarrhea, especially infections of intestinal cells by rotavirus; prevention of colonization of the intestine by pathogenic bacteria causing diarrhea; and an ability to adhere to and colonize the intestinal mucosa of a host organism.
[0053] Yet another advantage of the present invention is that it provides a composition beneficial for diabetics. This is due to the specific composition of macronutrients, protein, carbohydrate and fat which provides a low glycemic index.
[0054] Additional features and advantages of the present invention are described in, and will be apparent from the description of the presently preferred embodiments which are set out below.

Problems solved by technology

For instance, a reduction in the number of functioning cells and the resultant slowing of metabolic processes results in a decrease in caloric requirements among the elderly.
Also, the reduction in physical activity that generally accompanies aging further decreases energy requirements.
Merely decreasing the total caloric intake of an elderly patient may adversely affect their required nutrition.
Naturally, standard formulae do not take into account the nutritional needs of an elderly patient.
Standard products suffer from the problem that they must be supplemented with key micronutrients to compensate for common deficiencies and metabolic changes of an elderly patient.
Furthermore, it is known that the problem of an impaired immune response can be associated with aging, chronic pathological conditions and / or malnutrition.
However, these supplements suffer from the problem that, generally, they are specific for certain ailments and do not provide good nutritional support for patients suffering from a more complicated combination of conditions.
In addition, the increase in the likelihood of chronic disease such as arthritis, gastritis, etc, with age leads to an increase in inflammatory reactions.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

examples

[0066] The following examples are given by way of illustration only and in no way should be construed as limiting the subject matter of the present application. Percentages and parts are by weight unless otherwise indicated.

examples 1 and 2

Nutritional Compositions

[0067] Two nutritional compositions were made by blending the required constituents. Their compositions are indicated below in table 1. The compositions are intended to be consumed in the form of two oral supplements per day based on enriched beverages or milk product desserts. The total daily dose is intended to be approximately 300 g or 300 ml of composition.

TABLE IDaily dose 300 ml / dayDaily dose 300 ml / dayEnergy480kcal300kcal(1.6kcal / ml)(1.0kcal / ml)P / L / C % TEI26% / 24% / 51%28% / 30% / 42%Protein g / 100 ml10.57.0(with 6.25 gsoy protein)Fat g / 100 ml4.163.3Carbohydrate g / 100 ml20.610.5in daily doseper 300mlper 300mlNa mg188188K mg350350Cl mg290290Ca mg200200P mg150150Ca / P ratio1.31.3Mg mg6060Mn μg495495A IU13331333D IU100100E IU120150K1 μg13.813.8C mg120120B1 mg0.250.25B2 mg0.30.3Niacin mg33B6 mg2.02.0Folic acid μg400600Panto mg1.001.00B12 μg3.810.0Biotin μg7.57.5Fe mg2.752.75I μg7575Cu mg1.51.5Zn mg156Se μg100100Cr μg12.512.5Mo μg18.7518.75Inulin & FOS blend66(30...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
energyaaaaaaaaaa
compositionaaaaaaaaaa
physical activityaaaaaaaaaa
Login to view more

Abstract

A nutritional composition is described for prevention or treatment of an immune condition. The composition includes at least vitamin E, vitamin C, vitamin B6, folic acid, vitamin B12, copper, zinc, selenium, fructo-oligosaccharides and / or gum acacia, a probiotic lactic acid bacterium. For example, in an embodiment it comprises per 300 g: 150 IU Vitamin E, 120 mg Vitamin C, 2 mg Vitamin B6, 400 ug Folic acid, 3.8 ug Vitamin B12, 1.5 mg Copper, 15 mg Zinc, 100 ug Selenium, 3 g Fructo-oligosaccharides and / or gum acacia, 10E10 cfu ST11 lactobacillus. Also disclosed are a method for making the nutritional composition, a method for manufacturing a functional food or medicament; and a method of prevention or treatment of an immune condition by administering an effective amount of the composition, functional food or medicament.

Description

CROSS-REFERENCE TO RELATED APPLICATION [0001] This application is a continuation of the US national phase of International application PCT / EPO1 / 13302 filed Nov. 14, 2001, the content of which is expressly incorporated herein by reference thereto.BACKGROUND ART [0002] The present invention relates to a nutritional composition for prevention or treatment of an immune condition, a method of production of the composition, use of the composition in the manufacture of a functional food or medicament for the prevention or treatment of an immune condition and a method of treatment of an immune condition which comprises administering an effective amount of the composition. [0003] At the turn of the century, Americans older than 65 years old accounted for 4% of the US population. Currently, they account for greater than 12% of the population. However, although they only account for 12% of the US population, they account for greater than 40% of acute hospital bed days, buy greater than 30% of ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): A23C9/13A23L1/304A23L1/30A23L1/305A23L29/00A23L29/206A23L29/244A23L33/00A23L33/15A23L33/155A61K9/16A61K31/23A61K31/355A61K31/375A61K31/4415A61K31/525A61K31/565A61K31/59A61K31/702A61K31/714A61K31/715A61K31/733A61K33/04A61K33/06A61K33/30A61K33/34A61K33/42A61K35/12A61K35/20A61K38/00A61K38/01A61K47/36A61P1/04A61P1/14A61P3/00A61P3/02A61P19/02A61P29/00A61P37/00A61P43/00C12N1/21
CPCA23C9/1307A61K35/744A23L1/0345A23L1/0528A23L1/302A23L1/303A23L1/304A23V2002/00A61K31/355A61K31/375A61K33/04A61K33/30A61K33/34A61K35/20A61K38/018A23C9/1322A61K2300/00A23V2250/5062A23V2250/206A23V2250/1626A23V2250/1642A23V2250/1588A23V2250/1578A23V2250/156A23V2250/70A23V2250/5022A23V2250/712A23V2250/708A23V2250/704A23V2250/702A23V2250/71A23V2250/7052A23V2250/706A23L29/065A23L29/244A23L33/15A23L33/155A23L33/16A61P1/04A61P1/14A61P19/02A61P29/00A61P3/00A61P3/02A61P37/00A61P37/02A61P37/04A61P43/00A23L33/00
Inventor SPIVEY-KROBATH, EVELYNCAVADINI, CLAUDEHASCHKE, FERDINANDJAUSSAN, VERONIQUESCHIFFRIN, EDUARDO
Owner NESTEC SA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products